Magnesium in Pediatric Nephrotic Syndrome
Summary
Children with active nephrotic syndrome (NS) show significantly lower serum magnesium (Mg) levels compared to healthy children. Monitoring Mg levels may aid in diagnosing and treating acute nephropathy in pediatric patients.
Area of Science:
- Pediatric Nephrology
- Clinical Biochemistry
- Renal Medicine
Background:
- Nephrotic syndrome (NS) is a complex kidney disorder affecting children.
- The role of serum magnesium (Mg) in the pathophysiology and progression of NS requires further elucidation.
- Understanding electrolyte imbalances is crucial for managing pediatric renal diseases.
Purpose of the Study:
- To evaluate serum Mg concentration in pediatric patients diagnosed with nephrotic syndrome.
- To investigate the relationship between serum Mg levels and the acute phase of nephropathy in children.
- To explore the potential diagnostic and therapeutic implications of Mg variations in NS.
Main Methods:
- A clinical study involving 27 children (2-17 years) with idiopathic nephrotic syndrome (NS) during first episode or relapse.
- Serum and urinary levels of magnesium (Mg) were assessed alongside other renal function markers (urea, creatinine, protein, cholesterol).
- A control group of 14 healthy children with normal renal function was included for comparison.
Main Results:
- Significantly decreased serum Mg levels were observed in the active NS group compared to the control group.
- Patients with NS in the acute phase exhibited lower Mg concentrations.
- Renal histopathology in steroid-responsive patients showed minimal mesangial changes, IgM nephropathy, and mesangioproliferative glomerulonephritis.
Conclusions:
- Serum and urinary Mg level variations in children with acute nephropathy may serve as valuable indicators.
- Monitoring Mg levels could potentially aid in the early diagnosis of acute nephropathy in pediatric NS.
- Findings suggest that Mg assessment may contribute to improving therapeutic strategies for NS.
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
655
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
655
01:26Nephrotic Syndrome II : Assessment and Medical Management
246
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
246
01:24Nephrotic Syndrome III : Nursing Management
333
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
333
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
314
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
236
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
236